Back to Search
JEFFREY BLOOMER, MD
MD
Pulmonary Disease Physician
NPI: 1457449449IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
35-042156(OH)
Education
UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Class of 1977
Research & Publications (20)
Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".
PMID 19679676·Drug Metab Dispos·2009
4-observational
Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation.
PMID 19280384·Xenobiotica·2009
8-other
Use of extracorporeal albumin dialysis for erythropoietic protoporphyria.
PMID 17457857·Liver Transpl·2007
8-other
Intermittent unexplained abdominal pain: is it porphyria?
PMID 17981245·Clin Gastroenterol Hepatol·2007
8-other
Comparison of 2-aminophenol and 4-nitrophenol as in vitro probe substrates for the major human hepatic sulfotransferase, SULT1A1, demonstrates improved selectivity with 2-aminophenol.
PMID 17506995·Biochem Pharmacol·2007
4-observational
Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria.
PMID 17074841·Pediatrics·2006
5-case
Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
PMID 16819399·J Pediatr Gastroenterol Nutr·2006
8-other
A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation.
PMID 16611025·Curr Drug Metab·2006
6-review
Liver transplantation for erythropoietic protoporphyria liver disease.
PMID 16315313·Liver Transpl·2005
4-observational
Straight talk--new approaches in healthcare. The road to a digital healthcare community. Panel discussion.
PMID 15977680·Mod Healthc·2005
8-other
Molecular studies of liver disease in erythropoietic protoporphyria.
PMID 15758654·J Clin Gastroenterol·2005
6-review
Recommendations for the diagnosis and treatment of the acute porphyrias.
PMID 15767622·Ann Intern Med·2005
6-review
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
PMID 12643913·Bioorg Med Chem Lett·2003
7-preclinical
Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria.
PMID 11923691·Transplantation·2002
5-case
Curricular guidelines for training in transplant hepatology.
PMID 11799493·Liver Transpl·2002
6-review
Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.
PMID 11929052·Cell Mol Biol (Noisy-le-grand)·2002
8-other
Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations.
PMID 12063482·J Am Acad Dermatol·2002
5-case
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man.
PMID 12182870·Bioorg Med Chem Lett·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4760 E GALBRAITH RD, SUITE 206
CINCINNATI, OH 45236 - Phone
- (513) 791-4490
Quick Facts
- NPI
- 1457449449
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile